6[6]Joannides R,Haefeli WE,Linder L,et al JF:Nitric oxide is responsible for flow-depen-dent dilatation of human peripheral conduit arteries in vivo.Circulation 1995;91:1314～1319.
7[7]Giannattasio C,Mancia G.Arterial disten sibility in humans.Modulating Mechanisms,alterations in diseases and effects of treatment.Journal of Hypertension,2002,20:1889～1899.
8[8]Staessen J A,Fagard R,Thijs L.Randomized double-blind comparison of pllacebo and active treatment for older patients with isolated systolic hypertension.lancet,1997,350:757～764.
9[9]Lisheng L,Wang,JG.Systlic hypertension of china(Syst-China).Arch Int Med,2000,160:211～220.
10[10]Amery A.European Working Party on High Blood pressure in the Elderly trial(EWPHE).AM J Med,1991,90 Suppl 3A:3A,64S.
2Grey E,Bratteli C,Glasser S P,et al.Small But Not Large Artery Compliance Predicts Cardiovascular Events.American Journal Hypertension,2000,4:B059.
3Grey E,Christopher W,Dennis J,et al.Age-Related Abnormalities in Arterial Compliance Identified by Pressure Pulse Contour Analysis.Hypertension,1999,33:1392～1398.
4Stelhen P.Glasser,Donna K.Arnett,Gary E.Mcveigh,et al.Vascular Compliance and Cardiovascular Disease.AJH,1997,10:1175～1189.
5Jay N.cohn,Stanley Finkelstein,Gary Mcveigh,et al.Noninvasive Pulse Wave Analysis for the Early Detection of Vascular Disease.Hypertension,1995,3:503～508.
6Stephen P.Glasser,MD,Donna K.Arnett,PhD,Gary E.Mcveigh,The lmportance of Arterial Compliance in Cardiovascular Drug Therapy.J Chin Pharmacology,1998,38:202～212.
